Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H G Heijerman

Showing results (11-20 of 45) with videos related to

Pageof 5
Sort By:
Therapeutic Drug Monitoring|April 1, 1996
Prospective evaluation of a dose prediction algorithm for intravenous tobramycin in adolescent and adult patients with cystic fibrosisD J Touw, A A Vinks, H G Heijerman, et al.
International Journal of Rehabilitation Research. Internationale Zeitschrift Fur Rehabilitationsforschung. Revue Internationale De Recherches De Readaptation|January 1, 1991
Oxygen-assisted exercise training in adult cystic fibrosis patients with pulmonary limitation to exerciseH G Heijerman, W Bakker, P J Sterk, et al.
Scandinavian Journal of Gastroenterology. Supplement|January 1, 1990
Ranitidine compared with the dimethylprostaglandin E2 analogue enprostil as adjunct to pancreatic enzyme replacement in adult cystic fibrosisH G Heijerman, C B Lamers, J H Dijkman, et al.
The Journal of Antimicrobial Chemotherapy|July 1, 1997
Continuous infusion of ceftazidime in cystic fibrosis patients during home treatment: clinical outcome, microbiology and pharmacokineticsA A Vinks, R W Brimicombe, H G Heijerman, et al.
Digestive Diseases and Sciences|January 1, 1993
Improvement of fecal fat excretion after addition of omeprazole to pancrease in cystic fibrosis is related to residual exocrine function of the pancreasH G Heijerman, C B Lamers, W Bakker, et al.
Therapeutic Drug Monitoring|February 1, 1993
Validation of tobramycin monitoring in adolescent and adult patients with cystic fibrosisD J Touw, A A Vinks, H G Heijerman, et al.
The Netherlands Journal of Medicine|October 1, 1992
Gallbladder disease in cystic fibrosisM C Jebbink, H G Heijerman, A A Masclee, et al.
European Journal of Gastroenterology & Hepatology|March 1, 1995
Erroneous diagnosis of distal intestinal obstruction syndrome in cystic fibrosis: clinical impact of abdominal ultrasonographyH Dik, J J Nicolai, J Schipper, et al.
Digestive Diseases and Sciences|December 17, 1997
Effect of omeprazole 40 mg once daily on intraduodenal and intragastric pH in H. pylori-negative healthy subjectsK H Gan, W P Geus, C B Lamers, et al.
The Netherlands Journal of Medicine|June 1, 1995
Present and future aspects of cystic fibrosisH G Heijerman, J van der Laag, J C de Jongste, et al.
Pageof 5

Showing results (11-20 of 45) with videos related to

Sort By:
Pageof 5
Therapeutic Drug Monitoring|April 1, 1996
Prospective evaluation of a dose prediction algorithm for intravenous tobramycin in adolescent and adult patients with cystic fibrosisD J Touw, A A Vinks, H G Heijerman, et al.
International Journal of Rehabilitation Research. Internationale Zeitschrift Fur Rehabilitationsforschung. Revue Internationale De Recherches De Readaptation|January 1, 1991
Oxygen-assisted exercise training in adult cystic fibrosis patients with pulmonary limitation to exerciseH G Heijerman, W Bakker, P J Sterk, et al.
Scandinavian Journal of Gastroenterology. Supplement|January 1, 1990
Ranitidine compared with the dimethylprostaglandin E2 analogue enprostil as adjunct to pancreatic enzyme replacement in adult cystic fibrosisH G Heijerman, C B Lamers, J H Dijkman, et al.
The Journal of Antimicrobial Chemotherapy|July 1, 1997
Continuous infusion of ceftazidime in cystic fibrosis patients during home treatment: clinical outcome, microbiology and pharmacokineticsA A Vinks, R W Brimicombe, H G Heijerman, et al.
Digestive Diseases and Sciences|January 1, 1993
Improvement of fecal fat excretion after addition of omeprazole to pancrease in cystic fibrosis is related to residual exocrine function of the pancreasH G Heijerman, C B Lamers, W Bakker, et al.
Therapeutic Drug Monitoring|February 1, 1993
Validation of tobramycin monitoring in adolescent and adult patients with cystic fibrosisD J Touw, A A Vinks, H G Heijerman, et al.
The Netherlands Journal of Medicine|October 1, 1992
Gallbladder disease in cystic fibrosisM C Jebbink, H G Heijerman, A A Masclee, et al.
European Journal of Gastroenterology & Hepatology|March 1, 1995
Erroneous diagnosis of distal intestinal obstruction syndrome in cystic fibrosis: clinical impact of abdominal ultrasonographyH Dik, J J Nicolai, J Schipper, et al.
Digestive Diseases and Sciences|December 17, 1997
Effect of omeprazole 40 mg once daily on intraduodenal and intragastric pH in H. pylori-negative healthy subjectsK H Gan, W P Geus, C B Lamers, et al.
The Netherlands Journal of Medicine|June 1, 1995
Present and future aspects of cystic fibrosisH G Heijerman, J van der Laag, J C de Jongste, et al.
Pageof 5